Sofosbuvir (CAS 1190307-88-0) Market Report

Global and Region Sofosbuvir (CAS 1190307-88-0) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Aug 02, 2022
  • PAGES：218
  • REPORT CODE：GMM1006562
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Sofosbuvir (CAS 1190307-88-0) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Sofosbuvir (CAS 1190307-88-0)market, defines the market attractiveness level of Sofosbuvir (CAS 1190307-88-0) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Sofosbuvir (CAS 1190307-88-0) industry, describes the types of Sofosbuvir (CAS 1190307-88-0) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sofosbuvir (CAS 1190307-88-0) market and the development prospects and opportunities of Sofosbuvir (CAS 1190307-88-0) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sofosbuvir (CAS 1190307-88-0) market in Chapter 13.

    By Player:

    • NIFTY LABS PVT LTD

    • Manus Aktteva Biopharma LLP

    • SMS Pharmaceuticals Limited

    • Teva Pharmaceutical Industries Ltd

    • Hangzhou Longshine Bio-Tech Co

    • Sinobright Pharmaceutical Company Limited

    • Beijing Kawin Technology Share-holding Co

    • DEAFARMA

    • Tecoland

    By Type:

    • Above 98% Purity

    • Below 98% Purity

    By End-User:

    • 400mg Tablets

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Sofosbuvir (CAS 1190307-88-0) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Sofosbuvir (CAS 1190307-88-0) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Sofosbuvir (CAS 1190307-88-0) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Sofosbuvir (CAS 1190307-88-0) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Sofosbuvir (CAS 1190307-88-0) Market Analysis and Outlook to 2022

    • 7.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption (2017-2022)

    • 7.2 United States Sofosbuvir (CAS 1190307-88-0) Consumption (2017-2022)

    • 7.3 Europe Sofosbuvir (CAS 1190307-88-0) Consumption (2017-2022)

    • 7.4 China Sofosbuvir (CAS 1190307-88-0) Consumption (2017-2022)

    • 7.5 Japan Sofosbuvir (CAS 1190307-88-0) Consumption (2017-2022)

    • 7.6 India Sofosbuvir (CAS 1190307-88-0) Consumption (2017-2022)

    • 7.7 South Korea Sofosbuvir (CAS 1190307-88-0) Consumption (2017-2022)

    8 Region and Country-wise Sofosbuvir (CAS 1190307-88-0) Market Analysis and Outlook to 2028

    • 8.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption Forecast (2022-2028)

    • 8.2 United States Sofosbuvir (CAS 1190307-88-0) Consumption Forecast (2022-2028)

    • 8.3 Europe Sofosbuvir (CAS 1190307-88-0) Consumption Forecast (2022-2028)

    • 8.4 China Sofosbuvir (CAS 1190307-88-0) Consumption Forecast (2022-2028)

    • 8.5 Japan Sofosbuvir (CAS 1190307-88-0) Consumption Forecast (2022-2028)

    • 8.6 India Sofosbuvir (CAS 1190307-88-0) Consumption Forecast (2022-2028)

    • 8.7 South Korea Sofosbuvir (CAS 1190307-88-0) Consumption Forecast (2022-2028)

    9 Global Sofosbuvir (CAS 1190307-88-0) Market Outlook by Types and Applications to 2022

    • 9.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Above 98% Purity Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Below 98% Purity Consumption and Growth Rate (2017-2022)

    • 9.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global 400mg Tablets Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Sofosbuvir (CAS 1190307-88-0) Market Outlook by Types and Applications to 2028

    • 10.1 Global Sofosbuvir (CAS 1190307-88-0) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global Above 98% Purity Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Below 98% Purity Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Sofosbuvir (CAS 1190307-88-0) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global 400mg Tablets Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Sofosbuvir (CAS 1190307-88-0) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Sofosbuvir (CAS 1190307-88-0) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Sofosbuvir (CAS 1190307-88-0) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Sofosbuvir (CAS 1190307-88-0) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Sofosbuvir (CAS 1190307-88-0) Market Competitive Analysis

    • 14.1 NIFTY LABS PVT LTD

      • 14.1.1 NIFTY LABS PVT LTD Company Details

      • 14.1.2 NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Product and Service

    • 14.2 Manus Aktteva Biopharma LLP

      • 14.2.1 Manus Aktteva Biopharma LLP Company Details

      • 14.2.2 Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Product and Service

    • 14.3 SMS Pharmaceuticals Limited

      • 14.3.1 SMS Pharmaceuticals Limited Company Details

      • 14.3.2 SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Product and Service

    • 14.4 Teva Pharmaceutical Industries Ltd

      • 14.4.1 Teva Pharmaceutical Industries Ltd Company Details

      • 14.4.2 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product and Service

    • 14.5 Hangzhou Longshine Bio-Tech Co

      • 14.5.1 Hangzhou Longshine Bio-Tech Co Company Details

      • 14.5.2 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product and Service

    • 14.6 Sinobright Pharmaceutical Company Limited

      • 14.6.1 Sinobright Pharmaceutical Company Limited Company Details

      • 14.6.2 Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Product and Service

    • 14.7 Beijing Kawin Technology Share-holding Co

      • 14.7.1 Beijing Kawin Technology Share-holding Co Company Details

      • 14.7.2 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product and Service

    • 14.8 DEAFARMA

      • 14.8.1 DEAFARMA Company Details

      • 14.8.2 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product and Service

    • 14.9 Tecoland

      • 14.9.1 Tecoland Company Details

      • 14.9.2 Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Tecoland Sofosbuvir (CAS 1190307-88-0) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Sofosbuvir (CAS 1190307-88-0)

    • Figure Sofosbuvir (CAS 1190307-88-0) Picture

    • Table Global Sofosbuvir (CAS 1190307-88-0) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Consumption by Country (2017-2022)

    • Figure United States Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2017-2022)

    • Table Europe Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2017-2022)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2017-2022)

    • Figure Japan Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2017-2022)

    • Figure India Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Sofosbuvir (CAS 1190307-88-0) Consumption and Growth Rate (2017-2022)

    • Figure Global Sofosbuvir (CAS 1190307-88-0) Consumption Forecast by Country (2022-2028)

    • Figure United States Sofosbuvir (CAS 1190307-88-0) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Sofosbuvir (CAS 1190307-88-0) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Sofosbuvir (CAS 1190307-88-0) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Sofosbuvir (CAS 1190307-88-0) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Sofosbuvir (CAS 1190307-88-0) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Sofosbuvir (CAS 1190307-88-0) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Above 98% Purity Consumption and Growth Rate (2017-2022)

    • Figure Global Below 98% Purity Consumption and Growth Rate (2017-2022)

    • Figure Global 400mg Tablets Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Above 98% Purity Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Below 98% Purity Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global 400mg Tablets Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Sofosbuvir (CAS 1190307-88-0) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Sofosbuvir (CAS 1190307-88-0) Export by Region (Top 5 Countries) (2017-2028)

    • Table NIFTY LABS PVT LTD (Foundation Year, Company Profile and etc.)

    • Table NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

    • Table NIFTY LABS PVT LTD Sofosbuvir (CAS 1190307-88-0) Product and Service

    • Table Manus Aktteva Biopharma LLP (Foundation Year, Company Profile and etc.)

    • Table Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Manus Aktteva Biopharma LLP Sofosbuvir (CAS 1190307-88-0) Product and Service

    • Table SMS Pharmaceuticals Limited (Foundation Year, Company Profile and etc.)

    • Table SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

    • Table SMS Pharmaceuticals Limited Sofosbuvir (CAS 1190307-88-0) Product and Service

    • Table Teva Pharmaceutical Industries Ltd (Foundation Year, Company Profile and etc.)

    • Table Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Pharmaceutical Industries Ltd Sofosbuvir (CAS 1190307-88-0) Product and Service

    • Table Hangzhou Longshine Bio-Tech Co (Foundation Year, Company Profile and etc.)

    • Table Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Hangzhou Longshine Bio-Tech Co Sofosbuvir (CAS 1190307-88-0) Product and Service

    • Table Sinobright Pharmaceutical Company Limited (Foundation Year, Company Profile and etc.)

    • Table Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sinobright Pharmaceutical Company Limited Sofosbuvir (CAS 1190307-88-0) Product and Service

    • Table Beijing Kawin Technology Share-holding Co (Foundation Year, Company Profile and etc.)

    • Table Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Beijing Kawin Technology Share-holding Co Sofosbuvir (CAS 1190307-88-0) Product and Service

    • Table DEAFARMA (Foundation Year, Company Profile and etc.)

    • Table DEAFARMA Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

    • Table DEAFARMA Sofosbuvir (CAS 1190307-88-0) Product and Service

    • Table Tecoland (Foundation Year, Company Profile and etc.)

    • Table Tecoland Sofosbuvir (CAS 1190307-88-0) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Tecoland Sofosbuvir (CAS 1190307-88-0) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US